重组甲状旁腺激素相关蛋白1-36及其在促进牙槽骨骨形成中的作用

doi:10.19439/j.sjos.2020.06.004

上海口腔医学 ›› 2020, Vol. 29 ›› Issue (6): 580-585.doi: 10.19439/j.sjos.2020.06.004

重组甲状旁腺激素相关蛋白1-36及其在促进牙槽骨骨形成中的作用

李琴^1,2, 吕春华^2,3, 陈玲^2,4, 刘贤^1,2, 王华², 孙雯²

1.常州市口腔医院口腔内科,江苏常州 213003;
2.南京医科大学口腔疾病研究江苏省重点实验室,江苏南京 210029;
3.泰州市人民医院口腔科,江苏泰州 225300;
4.上海同仁医院口腔科,上海 200050

收稿日期:2019-03-17 修回日期:2019-05-15 出版日期:2020-12-25 发布日期:2021-01-08
通讯作者: 孙雯,E-mail：wensun@njmu.edu.cn
作者简介:李琴（1981-）,女,硕士,副主任医师,E-mail: lq.11@163.com
基金资助:
江苏省口腔疾病研究重点实验室开放课题（JSKLOD-KF-1706）; 江苏省口腔疾病研究重点实验室开放课题（JSKLOD-KF-1707）; 高等学校博士学科点专项科研基金-新教师类（20123234120007）

Synthetic PTHrP1-36 and its role in promoting alveolar bone formation

LI Qin^1,2, LYU Chun-hua^2,3, CHEN Lin^2,4, LIU Xian^1,2, WANG Hua², SUN Wen²

1. Department of Operative Dentistry, Changzhou Stomatology Hospital. Changzhou 213003, Jiangsu Province;
2. Jiangsu Key Laboratory of Oral Diseases, Nanjing Medical University. Nanjing 210029, Jiangsu Province;
3. Department of Stomatology, Taizhou People's Hospital. Taizhou 225300, Jiangsu Province;
4. Department of Stomatology, Shanghai Tongren Hospital. Shanghai 200050, China

Received:2019-03-17 Revised:2019-05-15 Online:2020-12-25 Published:2021-01-08

摘要/Abstract

摘要： 目的： 构建重组甲状旁腺激素相关蛋白(parathyroid hormone related protein, PTHrP)1-36并观察其在促进牙槽骨骨形成中的作用。方法： 构建pGEX-2TK/ PTHrP1-36原核表达载体,表达重组小鼠PTHrP1-36蛋白。通过处理小鼠原代骨髓间充质细胞和卵巢切除致颌骨疏松的小鼠,体外和体内观察重组PTHrP1-36在促进牙槽骨骨形成中的作用。采用SPSS 10.0软件包对数据进行统计学分析。结果： 实验结果显示,pGEX-2TK/ PTHrP1-36原核表达载体构建成功,IPTG可诱导新生蛋白表达。体外处理小鼠骨髓细胞,发现重组PTHrP1-36蛋白可以增加总成纤维细胞克隆形成单位(CFU-f)、碱性磷酸酶阳性的CFU-f和钙化结节的数目。在卵巢切除致颌骨疏松的小鼠体内注射重组PTHrP1-36蛋白,发现小鼠牙槽骨骨密度增加。H-E染色以及骨胶原染色显示,牙槽骨骨量明显增加。结论： 重组PTHrP1-36可促进骨髓间充质细胞的成骨分化,促进牙槽骨骨密度和骨量的增加,提示PTHrP1-36在促进牙槽骨形成中具有积极作用。

关键词: 甲状旁腺激素相关蛋白, 牙槽骨, 骨原细胞, 重组蛋白

Abstract: PURPOSE: To synthetise mouse parathyroid hormone related protein 1-36 (PTHrP1-36) and to study its role in promoting alveolar bone formation. METHODS: pGEX-2TK/ PTHrP1-36 was constructed and PTHrP1-36 was expressed. The role of PTHrP1-36 in promoting alveolar bone formation was observed by treating bone marrow cells in vitro and ovariectomy-induced maxillofacial osteoporosis in vivo. Statistical analysis was performed using SPSS 10.0 software package. RESULTS: The results of PCR analysis showed that pGEX-2TK/ PTHrP1-36 plasmid was correct templates for expressing PTHrP1-36. The molecular weights obtained by SDS-PAGE were the same as the theoretical value after IPTG induction. Scale up production was carried out by 3-hour-induction with 1mM IPTG which was the optimal induction factors. Bone marrow cell culture revealed that synthetic PTHrP1-36 increased the number of total fibroblastic colony forming units (CFU-f), ALP positive CFU-f and calcific nodules. After PTHrP1-36 was subcutaneously administered to ovariectomy mice, density and volume of alveolar bone were improved, as showed by X-ray and histochemistry staining of collagen-l and H-E staining. CONCLUSIONS: Synthetic PTHrP1-36 can promote bone marrow cell osteogenic differentiation and increase alveolar bone formation.

Key words: Parathyroid hormone related protein, Alveolar bone, Osteoprogenitor, Synthetic protein

中图分类号:

R782.1

李琴, 吕春华, 陈玲, 刘贤, 王华, 孙雯. 重组甲状旁腺激素相关蛋白1-36及其在促进牙槽骨骨形成中的作用[J]. 上海口腔医学, 2020, 29(6): 580-585.

LI Qin, LYU Chun-hua, CHEN Lin, LIU Xian, WANG Hua, SUN Wen. Synthetic PTHrP1-36 and its role in promoting alveolar bone formation[J]. Shanghai Journal of Stomatology, 2020, 29(6): 580-585.

参考文献

[1] 关晓月, 钱华, 边专. 卵泡刺激素在女性绝经后骨质疏松及口腔骨吸收疾病中的研究[J]. 口腔医学研究, 2017, 33(5): 574-576.
[2] 文艺, 杨鸿旭, 刘倩, 等. 骨髓间充质干细胞联合血管内皮祖细胞修复骨质疏松性牙槽骨缺损[J]. 中国组织工程研究, 2016, 20(19): 2748-2755.
[3] 李晶, 艾红军, 洪岩松. 骨质疏松症SD大鼠废用残根对周围牙槽骨组织影响的研究[J].中国医科大学学报, 2015, 44(5): 400-404.
[4] Persson GR, Berglund J, Persson RE, et al.Prediction of hip and hand fractures in older persons with or without a diagnosis of periodontitis[J]. Bone, 2011, 48(3): 552-556.
[5] Suresh S, Kumar TS, Saraswathy PK, et al.Periodontitis and bone mineral density among pre and post menopausal women: a comparative study[J]. J Indian Soc Periodontol, 2010, 14(1): 30-34.
[6] Dempster DW, Cosman F, Kurland ES, et al.Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study[J]. J Bone Miner Res, 2001, 16(10): 1846-1853.
[7] Zhang J, Liao L, Li Y, et al.Parathyroid hormone-related peptide (1-34) promotes tooth eruption and inhibits osteogenesis of dental follicle cells during tooth development[J]. J Cell Physiol, 2019, 234(7): 11900-11911.
[8] Wang CJ, McCauley LK. Osteoporosis and periodontitis[J]. Curr Osteoporos Rep, 2016, 14(6): 284-291.
[9] Binte Anwar R, Tanaka M, Kohno S, et,al. Relationship between porotic changes in alveolar bone and spinal osteoporosis[J]. J Dent Res, 2007, 86(1): 52-57.
[10] Luna-Cabrera F, Justicia-Rull EA, Caricol-Pérez MP, et al.Incidence of hypercalcemia, hypercalciuria and related factors in patients treated with recombinant human parathyroid hormone (1-84)[J]. Minerva Med, 2012, 103(2): 103-110.
[11] Liu M, Kurimoto P, Zhang J, et al.Sclerostin and DKK1 inhibition preserves and augments alveolar bone volume and architecture in rats with alveolar bone loss[J]. J Dental Res, 2018, 97(9) : 1031-1038.
[12] Sun W, Wu J, Huang L, et al.PTHrP nuclear localization and carboxyl terminus sequences modulate dental and mandibular development in part via the action of p27[J]. Endocrinology, 2016, 157(4): 1372-1384.
[13] Miao D, Tong XK, Chan GK, et al.Parathyroid hormone-related peptide stimulates osteogenic cell proliferation through protein kinase C activation of the Ras/mitogen-activated protein kinase signaling pathway[J]. J Biol Chem, 2001, 276(34): 32204-32213.
[14] Miao D, He B, Jiang Y, et al.Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34[J]. J Clin Invest, 2005, 115(9): 2402-2411.
[15] Xue Y, Karaplis AC, Hendy GN, et al.Genetic models show that parathyroid hormone and 1,25-dihydroxyvitamin D3 play distinct and synergistic roles in postnatal mineral ion homeostasis and skeletal development[J]. Hum Mol Genet, 2005, 14(11): 1515-1528.

重组甲状旁腺激素相关蛋白1-36及其在促进牙槽骨骨形成中的作用

Synthetic PTHrP1-36 and its role in promoting alveolar bone formation

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	霍美玲, 雷颖, 辛欣, 张颖, 王瑞梅. 2种矫治器对轻中度Ⅰ类错𬌗患者前牙牙根及牙槽骨的影响[J]. 上海口腔医学, 2024, 33(4): 407-410.
[2]	林惠, 高云飞, 卫超, 王梦蕾, 马旭辉. 槐角提取物对雌激素缺乏性骨质疏松小鼠牙槽骨骨量的影响[J]. 上海口腔医学, 2024, 33(3): 255-259.
[3]	卜晓霜, 王晓, 潘涛华, 朱丽雷, 郭锦材. MB-PDT辅助基础治疗对下前牙牙槽骨角形吸收的临床疗效评价[J]. 上海口腔医学, 2024, 33(3): 265-268.
[4]	张民珍, 邝惠芳, 杨黎艳, 罗文. 小肠黏膜下层可吸收生物膜在牙槽骨缺损修复中的应用效果评价[J]. 上海口腔医学, 2024, 33(3): 279-284.
[5]	陈宏丽, 尹刚, 张海娟. 阿托伐他汀促进大鼠牙槽骨缺损愈合及对Wnt/β-catenin信号通路的影响[J]. 上海口腔医学, 2024, 33(2): 130-134.
[6]	苏娟娟, 陈洪婷, 王旭, 靳强, 王琳. PGE2、COX-2表达与牙槽骨成骨活性、内氧水平的关系[J]. 上海口腔医学, 2024, 33(1): 85-89.
[7]	周团锋, 杨雪, 张华, 张智勇, 陈全. 48例Locator种植覆盖全口义齿5年临床修复效果评价[J]. 上海口腔医学, 2024, 33(1): 90-96.
[8]	俞晓霏, 汪信洋, 李斌, 陈耀忠. 壳寡糖对骨质疏松伴牙周炎大鼠骨代谢及IKK/NF-κB通路的影响[J]. 上海口腔医学, 2023, 32(2): 137-142.
[9]	巨佳, 杨驰, 武和明, 赵吉宏, 成黎霏, 张欢, 冯斌, 胡开进. 黄牛煅烧骨填充材料用于拔牙后牙槽骨缺损修复的效果评价[J]. 上海口腔医学, 2023, 32(2): 198-202.
[10]	徐丽, 布春青, 康洁, 贾国涛, 宋昊, 张传臣, 张男, 韩发彬. MIRB标记人脱落乳牙牙髓干细胞移植修复大鼠牙槽骨缺损的实验研究[J]. 上海口腔医学, 2022, 31(6): 581-587.
[11]	周明智, 王林, 王亮, 吴可, 秦燕军, 赵春洋. 青少年安氏Ⅱ²类错畸形矫治后下颌骨的变化[J]. 上海口腔医学, 2022, 31(4): 389-394.
[12]	谢勤, 林珊, 林立, 李多. 青少年正畸上颌切牙不同内收方式对牙槽骨形态的影响[J]. 上海口腔医学, 2022, 31(3): 290-294.
[13]	林怡君, 鄢洁雅, 王天鸽, 周志捷, 廖盛轩, 毛丽霞, 刘加强. 减数正畸治疗中中切牙牙根及牙槽骨形态变化的锥形束CT测量分析[J]. 上海口腔医学, 2022, 31(2): 211-216.
[14]	张黎, 刘育菘, 吴芸菲, 符起亚. 壳寡糖对牙周炎大鼠牙槽骨吸收及Th17/Treg平衡和OPG/RANKL/RANK通路的影响[J]. 上海口腔医学, 2021, 30(3): 237-242.
[15]	熊际文, 周巍. 拔牙位点保存术对不同类型骨缺损患者骨增量的差异分析[J]. 上海口腔医学, 2020, 29(6): 623-627.